ClinicalTrials.govpublic full text
A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation
transplanted organ rejection, kidney transplant, stem cell therapy, anti-rejection medications, living donor kidney transplant, immune tolerance, immunosuppression, immunosuppressive medication, organ transplant rejection, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 979891
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.